MixCache.com Total Access
Unlimited reading and audiobooks for every book published by MixCache.com.
Included titles carry the MTA badge.
Learn more →
When Dr. Caleb Fischer implants the world's first genetically engineered pig heart into a dying man, the surgery is a triumph—clean anastomoses, strong sinus rhythm, a patient waking up with a second chance. But in the sterile glow of the OR, Caleb sees what the monitors don't: a faint, impossible webbing lacing the donor tissue, a microscopic architecture that no CRISPR edit explains. And Sarah Lin, the corporate geneticist who built the organ, is already walking away, making calls he wasn't meant to hear.
Forty miles back at the SynthoGene facility, the harvest logs don't match the FDA filings. The viral vectors weren't self-limiting. The "proprietary coating" in the preservation fluid isn't preventing rejection—it's rewriting the host's immune response in real time. As Arthur Reid recovers, his blood work shows something terrifying: human antibodies binding to porcine proteins that don't exist in any database. The graft isn't just surviving. It's *recruiting*.
Now Caleb is trapped between a biotech giant burying its trial data, a whistleblower who just turned up dead in cold storage, and a patient whose new heart is beating a rhythm no human genome encoded. The transplant was supposed to be a miracle. Instead, it just became patient zero.
Fiction
September 14, 2026
Click to order this paperback:
Buy Now